Article Dans Une Revue New England Journal of Medicine Année : 2024

Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia

Dates et versions

hal-04809664 , version 1 (28-11-2024)

Identifiants

Citer

Kyriakie Sarafoglou, Mimi Kim, Maya Lodish, Eric Felner, Laetitia Martinerie, et al.. Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia. New England Journal of Medicine, 2024, 391 (6), pp.493-503. ⟨10.1056/NEJMoa2404655⟩. ⟨hal-04809664⟩
57 Consultations
0 Téléchargements

Altmetric

Partager

  • More